By Robert Bekimi

Valentine Nwanelo, a doctoral candidate at Wayne State University with a team of researchers, have identified a novel biological pathway that could revolutionize cancer treatment.

Valentine’s research focuses on histone deacetylase (HDAC) enzymes, which play a critical role in cancer development and progression. Aimed at understanding the molecular mechanism of cancer and finding therapeutic interventions, Valentine has published on the discovery of a new HDAC6 substrate in one of the leading journals in the United States.

In a groundbreaking discovery, Valentine and his research team revealed that HUWE1, an E3-ligase, is a deacetylase substrate of HDAC6 using advanced cellular and molecular biology techniques. Their work unveiled a previously unknown molecular mechanism involving HDAC6 deacetylation of HUWE1 to regulate other myriads of proteins that contribute to cancer progression. Their findings provide new insights into how cancer cells proliferate and metastasize, opening avenues for innovative therapeutic strategies.

Valentine’s discovery not only advances the field of cancer therapies but also underscores the essential role of biochemistry and cell biology in shaping the future of cancer treatments.

Cancer remains one of the leading health challenges in the United States, with over two million new cases and more than 600,000 deaths reported in 2025 alone. While current FDA-approved HDAC inhibitors—such as Vorinostat, Romidepsin, Panobinostat, and Belinostat—have demonstrated anticancer activity, they are often limited by severe side effects.

By establishing the connection between HDAC6 and HUWE1, their work sets the stage for the development of next-generation HDAC inhibitors with greater precision, improved effectiveness, and reduced toxicity.

Discoveries like this redefine how we understand cancer biology and this breakthrough could provide pharmaceutical companies with a promising new target for drug development.
This milestone highlights not only the advancement of cancer research but also the growing contributions of African scientists to global health innovation.